Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative melatonin versus gabapentin for rebound pain and anxiety after unilateral mandibulectomy with inferior alveolar nerve block
PACTR202502833693256Phase 0Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, double-blind trial of melatonin, gabapentin and Placebo-COD Research Private Ltd in cancer, anxiety disorder and postoperative pain (3 arms), sponsored by Mansoura University. Primary endpoint: Prevalence of postoperative rebound pain. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
melatoningabapentinPlacebo-COD Research Private Ltd
03
Conditions
canceranxiety disorderpostoperative pain
Beyond the preview
Go deeper on PACTR202502833693256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502833693256.